| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Aug 2025 | 5 Aug 2025 |
| Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the following business: 1. To consider and approve the Un-Audited Financial Results for the quarter ended June 30 2025 along with the Limited Review Report thereon. 2. To consider and approve the Notice of the 83rd Annual General Meeting of the Company for the year ended March 31 2025. 3. To consider and fix Book Closure along with Record Date for the forthcoming Annual General Meeting of the Company. 4. To consider the proposal for change of Name of the Company. 5. To consider the proposal to change the Main Object of the Company & alteration in Object Clause of Memorandum of Association of the Company. 6. To consider the proposal for shifting of the Registered Office of the Company from the State of Maharashtra to State of Gujarat. 7. To consider and approve appointment of Scrutinizer for the forthcoming 83rd Annual General Meeting of the Company. 8. Any other business with the permission of the Chair. | ||
| Board Meeting | 31 Jul 2025 | 28 Jul 2025 |
| Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve 1. To consider and accept resignation of existing statutory auditors. 2. To appoint fresh statutory auditors to fill the casual vacancy cause due to resignation of existing statutory auditor. Outcome of Board Meeting. INTIMATION OF APPOINTMENT OF STATUTORY AUDITOR. 1. Resignation of Statutory Auditor: The Board of Directors noted and accepted the resignation of M/s Sanjay Rane & Associates LLP, Chartered Accountants (Firm Registration No. 121089W/W100878), due to pre-occupation in other assignments. 2. Appointment of Statutory Auditor: The Board of Directors, subject to approval of shareholders to be obtained at the General meeting of the company, have recommended the appointment of M/s. S S R V & Associates, Chartered Accountants (FRN: 135901W), Mumbai as Statutory Auditors of the Company to fill the casual vacancy caused due to the resignation of M/s. Sanjay Rane & Associates LLP. (As Per BSE Announcement Dated on :31.07.2025) | ||
| Board Meeting | 29 May 2025 | 14 May 2025 |
| Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve the Audited Financial Results for the quarter and year ended March 31 2025 along with the Auditors Report thereon. Outcome of Board Meeting held on May 29, 2025 (As Per BSE Announcement Dated on: 29/05/2025) | ||
| Board Meeting | 2 May 2025 | 2 May 2025 |
| Outcome of Board Meeting Held on Friday, May 02, 2025. | ||
| Board Meeting | 16 Apr 2025 | 8 Apr 2025 |
| Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/04/2025 inter alia to consider and approve Appointment of Directors and Resignation appointment of Company Secretary and Compliance Officer and resignation board meeting intimation attach. OUTCOME OF THE BOARD MEETING HELD ON WEDNESDAY, APRIL 16, 2025 (As Per BSE Announcement Dated on: 16/04/2025) Reply to email dated 23/04/2025 regarding Additional detail required for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulation 2015 (As Per BSE Announcement dated on 23.04.2025) | ||
| Board Meeting | 27 Jan 2025 | 13 Jan 2025 |
| CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve the following businesses:- 1. To consider and approve the Un-Audited Financial Results for the quarter and nine months ended December 31 2024 along with the Limited Review Report. 2. Appointment of S K JAIN & Co. Membership No. 1473 and COP No. 3076 Company Secretaries as a Secretarial Auditor of the Company for the Financial Year 2024-25. Approved the Un-Audited Financial Results for the Quarter and Nine Months Ended December 31, 2024 2. Approved the Appointment of M/s S K Jain & Co. Practicing Company Secretary as the Secretarial Auditor of the Company for the Financial Year 2024-25. (As Per BSE Announcement Dated on: 27.01.2025) | ||
| Board Meeting | 28 Oct 2024 | 15 Oct 2024 |
| CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve the Un-Audited Financial Statements for the quarter and half year ended September 30 2024 along with the Limited Review Report thereon. Approval of Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2024 along with the Limited Review Report thereon. (As Per BSE Announcement Dated on: 28/10/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.